Spur Therapeutics
Clinical trials sponsored by Spur Therapeutics, explained in plain language.
-
Can a single gene infusion rewrite the story of fabry disease?
⭐️ CURE ⭐️ TerminatedThis trial is testing a gene therapy called FLT190 in adult men with classic Fabry disease, a genetic condition that causes harmful fat buildup in cells. The therapy uses a modified virus to deliver a working copy of the faulty gene, potentially enabling the body to produce the m…
Phase: PHASE1, PHASE2 • Sponsor: Spur Therapeutics • Aim: ⭐️ CURE ⭐️
Last updated Aug 08, 2026 00:03 UTC
-
Can a single gene shot free hemophilia b patients from regular infusions?
⭐️ CURE ⭐️ TerminatedThis trial tests a gene therapy called FLT180a in adults with hemophilia B, a condition where the body lacks a clotting protein. The therapy delivers a working gene to help the body produce its own clotting factor. A small group of participants will receive a single dose and be f…
Phase: PHASE1, PHASE2 • Sponsor: Spur Therapeutics • Aim: ⭐️ CURE ⭐️
Last updated Aug 02, 2026 00:00 UTC